BioSpace News Archive

Increasing Advancement, and Novel Innovations in the Treatment are Expected to Drive Hairy Cell Leukemia Market Revenue Growth by 2030 - Reports and Data

The latest market analysis report published by Reports and Data, titled ‘Global Hairy Cell Leukemia Market – Forecast to 2030,’ thoroughly examines the Hairy Cell Leukemia industry to provide essential data & information for the targeted readers.

September 21, 2022
·
6 min read
Pharm Country

Researchers Receive $4.2M Grant to Improve PrEP Access and Prevent New HIV Infections

Bronx county has the country’s fifth-highest rate of HIV diagnosis—but the lowest rate in New York State for use of HIV pre-exposure prophylaxis (PrEP), medications that are extremely effective in preventing HIV infection.

September 21, 2022
·
5 min read
Increased Biomarker Research and Development, and Availability of Advanced Therapeutic Medications are Expected to Drive Sezary Syndrome Treatment Market Revenue Growth by 2030 - Reports and Data

The latest market analysis report published by Reports and Data, titled ‘Global Sezary Syndrome Treatment Market – Forecast to 2030,’ thoroughly examines the Sezary Syndrome Treatment industry to provide essential data & information for the targeted readers.

September 21, 2022
·
6 min read
Increase in Incidence Rate of Thrombocytopenia, and Introduction of New Technologies is Expected to Drive Thrombocytopenia Market Revenue Growth by 2030 - Reports and Data

The latest market analysis report published by Reports and Data, titled ‘Global Thrombocytopenia Market – Forecast to 2030,’ thoroughly examines the Thrombocytopenia industry to provide essential data & information for the targeted readers.

September 21, 2022
·
6 min read
Minimal Residual Disease Market Size Worth USD 4,138.5 Million in 2030 | Emergen Research

The global Minimal Residual Disease (MRD) market size was USD 1,095.3 Million in 2021 and is expected to register a revenue CAGR of 16.04% during the forecast period, according to the latest analysis by Emergen Research.

September 21, 2022
·
6 min read
Multi Cancer Early Detection Market Size Worth USD 2,986.8 Million in 2030 | Emergen Research

The global Multi Cancer Early Detection (MCED) market size was USD 791.6 Million in 2021 and is expected to register a revenue CAGR of 15.8% during the forecast period, according to latest analysis by Emergen Research.

September 21, 2022
·
7 min read
Global Multiple Sclerosis (MS) Drugs Market Size to Reach USD 33.59 Billion 2030 | Emergen Research

The global Multiple Sclerosis drugs market size is expected to reach USD 33.59 Billion at a steady revenue CAGR of 3.9% in 2030, according to latest analysis by Emergen Research. Increasing prevalence of the disease and technological advancements in treatments are among key factors driving growth of the market.

September 21, 2022
·
6 min read
BioCapital

Latham BioPharm Group Announces Publication of Team Member’s Paper in Leading Scientific Journal

Latham Biopharm Group (LBG), in collaboration with researchers from RA Capital Management and Nostrum Biodiscovery, recently published a paper in the Journal of Chemical Information and Modeling (JCIM).

September 21, 2022
·
2 min read
AIM ImmunoTech to Present at the Virtual Investor Long COVID Event

AIM ImmunoTech Inc. today announced that it will participate in the Virtual Investor Long COVID Event on Wednesday, September 28, 2022 at 3:00 PM ET.

September 21, 2022
·
1 min read
Deals

Medtronic announces closing of public offering of €3.5 billion of senior notes

Medtronic plc (the “Company”) (NYSE: MDT) today announced that its wholly-owned subsidiary Medtronic Global Holdings S.C.A. ( “Medtronic Luxco”) has closed a registered public offering (the “Offering”) of €500,000,000 principal amount of 2.625% Senior Notes.

September 21, 2022
·
3 min read